FDA•Sep 8, 2026LOWFluphenazine HCl Tablets 1mgAjanta Pharma recalls Fluphenazine HCl 1mg tablets (NDC 27241-255-01) due to impurity out-of-specification.
FDA•Jun 22, 2026MODERATEFenofibrate Capsules, USP 200 mgAjanta Pharma is recalling Fenofibrate Capsules, USP 200 mg, due to manufacturing process deviations.
FDA•Jun 15, 2026MODERATEAripiprazole 30 mg TabletsAjanta Pharma is recalling Aripiprazole 30 mg tablets due to a mix-up with Voriconazole 50 mg tablets.
